Anúncio
Anúncio
PASG
Passage Bio, Inc. Common Stock
20.23
USDPatrocinado
+1.90
+10.34%
09 de jan., 15:58 UTC -5
Encerrado
Pós-Mercado
20.52
+0.30
+1.48%
Relatórios de Lucros PASG
Rácio de surpresa positiva
PASG separação 13 de 23 últimas estimativas.
57%
Próximo Relatório
Data do Próximo Relatório
02 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$2.62
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/+7.38%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/-34.50%
Passage Bio, Inc. Common Stock earnings per share and revenue
On 10 de nov. de 2025, PASG reported earnings of -2.44 USD per share (EPS) for Q3 25, beating the estimate of -2.85 USD, resulting in a 14.57% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +14.84% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 analistas forecast an EPS of -2.62 USD, with revenue projected to reach -- USD, implying an aumentar of 7.38% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
What were Passage Bio, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Passage Bio, Inc. Common Stock reported EPS of -$2.44, beating estimates by 14.57%, and revenue of $0.00, 0% as expectations.
How did the market react to Passage Bio, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 14.84%, changed from $6.71 before the earnings release to $7.70 the day after.
When is Passage Bio, Inc. Common Stock expected to report next?
The next earning report is scheduled for 02 de mar. de 2026.
What are the forecasts for Passage Bio, Inc. Common Stock's next earnings report?
Based on 8
analistas, Passage Bio, Inc. Common Stock is expected to report EPS of -$2.62 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio